$CRL News

Charles River Laboratories International (CRL) Contributed to Madison Small Cap Fund’s Healthcare Outperformance

Charles River Leverages Virtual Control Groups in GLP Studies

Charles River Laboratories' Virtual Control Group Database And Methodology To Be Used In An Upcoming Good Laboratory Practice-Compliant Study For Ipsen

Charles River Laboratories’ Q3 2026 Earnings: What to Expect

Labcorp, Charles River and FDA Announce Research Collaboration to Advance Preclinical Methods for Evaluating Drug Abuse Potential

Charles River, Labcorp, and FDA Collaborate to Validate New Preclinical Methods for Abuse Potential Assessment

Charles River Laboratories Announces Research Collaboration Agreement With FDA And Labcorp For Developing Sensitive Screening Tools To Quantify And Rank Abuse Potential Of New Drugs

Charles River Laboratories International (CRL) Partners With Magellan As Valuation Questions Linger

$1000 Invested In Charles River 15 Years Ago Would Be Worth This Much Today

Drug Development Inputs & Services Stocks Q2 In Review: Charles River Laboratories (NYSE:CRL) Vs Peers

Here’s How Much You Would Have Made Owning Charles River Stock In The Last 20 Years

Charles River partners with Magellan Stem Cells on cell therapy

Healthcare Contract Research Organization (CRO) - Global Strategic Business Report: Secure Share of US$63.3 Billion Market by 2032 as IQVIA, ICON, Charles River, and Syneos Health Accelerate AI Trials

Morgan Stanley Maintains Overweight on Charles River, Raises Price Target to $340

Charles River Collaborates with Magellan Stem Cells to Advance Stem Cell and Regenerative Medicine Development

Charles River Laboratories International Partners With Magellan Stem Cells For Development, Clinical Advancement Of Stem Cell-Based Therapies, Regenerative Medicine Solutions

Charles River Laboratories Schedules Third-Quarter 2026 Earnings Release and Conference Call

PGNY or CRL: Which Is the Better Value Stock Right Now?

Charles River Gains 75.8% in a Year: What's Driving the Rally?

Charles River and Autolomous Partner to Transform Laboratory Execution Systems